Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05821023 · ClinicalTrials.gov registry record · NA
Messaging Strategies to Reduce Breast Cancer Over-screening in Older Women
A NA study of Breast Cancer Screening, sponsored by Johns Hopkins University.
- Completed
- Registry status
- NA
- Development phase
- 4,173
- Enrollment target
- 1
- Study location
NCT05821023: Completed NA study of Breast Cancer Screening, sponsored by Johns Hopkins University.
NCT05821023 is a NA study of Breast Cancer Screening that has completed, run by Johns Hopkins University. The registered enrollment target is 4,173 participants, below the 62,920-participant average among 8 other Breast Cancer Screening trials with a reported enrollment target (93% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05821023, a NA study of Breast Cancer Screening, has completed, sponsored by Johns Hopkins University.
- COMPLETED
- Registry status
- NA
- Development phase
- 4,173 participants
- Enrollment target
- 1
- Study location
Study Summary
This is an online survey experiment with data collection over 2 time points two weeks apart. This is Aim 2 of a three-aim R01 project; overall project goal is to better understand how messages from different sources interact to affect older women's breast cancer screening decisions. In this current project, the investigators propose to test the effect of combined exposure to a clinician message + a message from another source (i.e. family/friend or media) on older women's breast cancer screening beliefs, attitudes, and intentions.
Primary Outcome
Screening intention for a hypothetical patient; assessed by score on a 7 point likert scale question developed by the investigators. 7= definitely should not get a mammogram (i.e. strong support for stopping screening) 1=definitely should get a mammogram (i.e. weak support for stopping screening)
Conditions Studied
Interventions
- OTHER messages
Study Locations (1)
Maryland
- Johns Hopkins University - Baltimore
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 4,173 participants |
| Start Date | 2023-05-12 |
| Est. Completion | 2023-06-19 |
| Phase | NA |
What the finished NCT05821023 record still lists
NCT05821023 is an interventional study that assigns participants to a tested intervention. Its 4,173 participants enrollment target places it among the larger protocols in the corpus, below the 62,920-participant average among 8 other Breast Cancer Screening trials with a reported enrollment target (93% lower).
The record links to 1 condition, with Breast Cancer Screening appearing as the primary indexed condition, and to 1 intervention - of which messages is the first listed.
NCT05821023 reports a single indexed study location in Maryland.
Frequently Asked Questions
What is clinical trial NCT05821023 about?
NCT05821023 is a clinical study titled "Messaging Strategies to Reduce Breast Cancer Over-screening in Older Women". This is an online survey experiment with data collection over 2 time points two weeks apart. This is Aim 2 of a three-aim R01 project; overall project goal is to better understand how messages from different sources interact to affect older women's breast cancer screening decisions. In this current ...
What is the current status of trial NCT05821023?
This trial is currently completed. It is a NA study. The enrollment target is 4,173 participants. The study started on 2023-05-12. Estimated completion is 2023-06-19.
What conditions does trial NCT05821023 study?
This clinical trial studies the following conditions: Breast Cancer Screening.
What interventions are being tested in trial NCT05821023?
The interventions under investigation include: messages (OTHER).
Who is sponsoring clinical trial NCT05821023?
This trial is sponsored by Johns Hopkins University, which has 1,448 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05821023 being conducted?
This trial has 1 study location across Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Breast Cancer Screening
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05821023's enrollment target sits among peer trials
4,173 3rd of 8 higher than 6 of 8 other Breast Cancer Screening trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Breast Cancer Screening trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
MADRE (Mammograms Available Due to Research and Education)
RECRUITING · NA
-
Women Informed to Screen Depending on Measures of Risk (Wisdom Study)
RECRUITING · NA
-
Adapting a Mammography Decision Aid to Support Women Living in a Community Contaminated by PFAS
COMPLETED · NA
-
Collaborative Care to Reduce Depression and Increase Cancer Screening Among Low-Income Urban Women
COMPLETED · NA
-
B.Brilliant Revelation Comparision Study
RECRUITING
-
A Trial Comparing Screening Mammography With and Without Assistance From Artificial Intelligence for Breast Cancer Detection and Recall Rates in Adult Patients
RECRUITING · Phase 4
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06593353 · 4,165 participants · NA
Systems Analysis and Improvement to Optimize Opioid Use Disorder Care Quality and Continuity for Patients Exiting Jail
- NCT02693535 · 4,200 participants · Phase 2
TAPUR: Testing the Use of Food and Drug Administration (FDA) Approved Drugs That Target a Specific Abnormality in a Tumor Gene in People With Advanced Stage Cancer
- NCT05969028 · 4,200 participants · NA
First Responder Airway & Compression Rate Trial
- NCT06935370 · 4,200 participants · Phase 3
A Study to Test Whether Vicadrostat (BI 690517) in Combination With Empagliflozin Helps People With Heart Failure and a Weak Pumping Function of the Left Side of the Heart
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI